In vivo bypass efficiencies and mutational signatures of the guanine oxidation products 2-aminoimidazolone and 5-guanidino-4-nitroimidazole.
about
Nitric oxide and peroxynitrite in health and diseaseBiological properties of single chemical-DNA adducts: a twenty year perspectiveChemical-biological fingerprinting: probing the properties of DNA lesions formed by peroxynitrite.Translesion DNA Synthesis.Transcription of DNA containing the 5-guanidino-4-nitroimidazole lesion by human RNA polymerase II and bacteriophage T7 RNA polymerase.The mutagenicity of thymidine glycol in Escherichia coli is increased when it is part of a tandem lesionChemical and biological consequences of oxidatively damaged guanine in DNA.Efficient and high fidelity incorporation of dCTP opposite 7,8-dihydro-8-oxodeoxyguanosine by Sulfolobus solfataricus DNA polymerase Dpo4.Occurrence, Biological Consequences, and Human Health Relevance of Oxidative Stress-Induced DNA Damage.Contiguous 2,2,4-triamino-5(2H)-oxazolone obstructs DNA synthesis by DNA polymerases α, β, η, ι, κ, REV1 and Klenow Fragment exo-, but not by DNA polymerase ζ.Generation, repair and replication of guanine oxidation products.Flexible 5-guanidino-4-nitroimidazole DNA lesions: structures and thermodynamics.DNA polymerase V allows bypass of toxic guanine oxidation products in vivo.
P2860
Q24645400-F2B57EC4-58F1-47AA-8FF2-698B04E43695Q33649960-5954817A-8F6B-4C9A-8A2A-659D6B863E1AQ33766500-983F6CB3-0313-404E-9FEF-DA31E26E5963Q34509062-CF55F140-7F39-4EB5-96A2-7057C1E93991Q36948658-93BD5B0C-6CFF-42D1-94A3-69CF2C184E31Q37310062-887A3AFD-0FB2-404C-AD8F-C57DA51C452DQ37975286-F69E70A7-F291-46BE-A6D7-131185A1CCF8Q38318506-4C24328F-FB53-45C6-B59F-75C64F5D3CD2Q38434331-9AD06999-8F22-47DE-8A5D-C7363E786344Q38592304-E6524222-C226-4A19-8612-B6CA53C27DB2Q41195935-59BAF714-824D-49EC-BFF3-A182E2E9027BQ41868010-AA19307D-A2FA-455D-9028-B0C7D56C2207Q54446139-4685D8A9-1DB5-49CC-8159-F5233C1D204D
P2860
In vivo bypass efficiencies and mutational signatures of the guanine oxidation products 2-aminoimidazolone and 5-guanidino-4-nitroimidazole.
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
In vivo bypass efficiencies an ...... 5-guanidino-4-nitroimidazole.
@ast
In vivo bypass efficiencies an ...... 5-guanidino-4-nitroimidazole.
@en
type
label
In vivo bypass efficiencies an ...... 5-guanidino-4-nitroimidazole.
@ast
In vivo bypass efficiencies an ...... 5-guanidino-4-nitroimidazole.
@en
prefLabel
In vivo bypass efficiencies an ...... 5-guanidino-4-nitroimidazole.
@ast
In vivo bypass efficiencies an ...... 5-guanidino-4-nitroimidazole.
@en
P2093
P356
P1476
In vivo bypass efficiencies an ...... 5-guanidino-4-nitroimidazole.
@en
P2093
James C Delaney
John M Essigmann
Paul T Henderson
William L Neeley
P304
43568-43573
P356
10.1074/JBC.M407117200
P407
P577
2004-08-06T00:00:00Z